Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation

被引:439
|
作者
Sato, S
Ward, CL
Krouse, ME
Wine, JJ
Kopito, RR
机构
[1] STANFORD UNIV,DEPT BIOL SCI,STANFORD,CA 94305
[2] STANFORD UNIV,DEPT PSYCHOL,CYST FIBROSIS RES LAB,STANFORD,CA 94305
关键词
D O I
10.1074/jbc.271.2.635
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The common Delta F508 mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) interferes with the biosynthetic folding of nascent CFTR polypeptides, leading to their retention and rapid degradation in an intracellular compartment proximal to the Gels apparatus, Neither the pathway by which wild-type CFTR folds nor the mechanism by which the Phe(508) deletion interferes with this process is well understood, We have investigated the effect of glycerol, a polyhydric alcohol known to stabilize protein conformation, on the folding of CFTR and Delta F508 in vivo. Incubation of transient and stable Delta F508 tranfectants with 10% glycerol induced a significant accumulation of Delta F508 protein bearing complex N-linked oligosaccharides, indicative of their transit to a compartment distal to the endoplasmic reticulum (ER). This accumulation was accompanied by an increase in mean whole cell cAMP activated chloride conductance, suggesting that the glycerol-rescued Delta F508 polypeptides form functional plasma membrane CFTR channels, These effects were dose- and time-dependent and fully reversible, Glycerol treatment also stabilized immature (core-glycosylated) Delta F508 and CFTR molecules that are normally degraded rapidly. These effects of glycerol were not due to a general disruption of ER quality control processes but appeared to correlate with the degree of temperature sensitivity of specific CFTR mutations, These data suggest a model in which glycerol serves to stabilize an otherwise unstable intermediate in CFTR biosynthesis, maintaining it in a conformation that is competent for folding and subsequent release from the ER quality control apparatus.
引用
收藏
页码:635 / 638
页数:4
相关论文
共 50 条
  • [31] Exoproducts of the Most Common Achromobacter Species in Cystic Fibrosis Evoke Similar Inflammatory Responses In Vitro
    Sahl, Cecilia
    Baumgarten, Maria
    Shannon, Oonagh
    Pahlman, Lisa I.
    [J]. MICROBIOLOGY SPECTRUM, 2023, 11 (04):
  • [32] SEVERE PHENOTYPE IN MICE WITH TERMINATION MUTATION IN EXON-2 OF CYSTIC-FIBROSIS GENE
    HASTY, P
    ONEAL, WK
    LIU, KQ
    MORRIS, AP
    BEBOK, Z
    SHUMYATSKY, GB
    JILLING, T
    SORSCHER, EJ
    BRADLEY, A
    BEAUDET, AL
    [J]. SOMATIC CELL AND MOLECULAR GENETICS, 1995, 21 (03) : 177 - 187
  • [33] Geographic distribution and phenotype of European people with cystic fibrosis carrying A1006E mutation
    Mondejar-Lopez, Pedro
    Zolin, Anna
    Garcia-Marcos, Patricia W.
    Dolores Pastor-Vivero, Ma
    Rosa-Silvestre, Maria
    de Asis Sanchez-Martinez, Francisco
    Salvatore, Donatello
    Cimino, Giuseppe
    Majo, Fabio
    Sole-Jover, Amparo
    Asensio de la Cruz, Oscar
    Adelaide Calderazzo, Maria
    Pizzamiglio, Giovanna
    Castillo-Corullon, Silvia
    Alvarez-Fernandez, Antonio
    Gartner, Silvia
    Padoan, Rita
    Carnovale, Vincenzo
    Salvatore, Marco
    Rosa Moya-Quiles, Ma
    Orenti, Annalisa
    Glover, Guillermo
    Sanchez-Solis, Manuel
    [J]. RESPIRATORY MEDICINE, 2022, 192
  • [34] Using mass spectrometry to understand cystic fibrosis as a protein misfolding disease
    Yates, John
    Pankow, Sandra
    Bamberger, Casimir
    Lavallee-Adam, Mathieu
    Izquierdo, Salvador Martinez de Bartolome
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [35] Idiosyncratic reactions are the most common cause of abnormal liver function tests in patients with cystic fibrosis
    Jong, T.
    Geake, J.
    Yerkovich, S.
    Bell, S. C.
    [J]. INTERNAL MEDICINE JOURNAL, 2015, 45 (04) : 395 - 401
  • [36] Novel contributions to the Asian CFTR mutation spectrum: Genotype and phenotype in Thai patients with cystic fibrosis
    Schrijver, I
    Karnsakul, W
    Limwongse, C
    Ramalingarn, S
    Sankaran, R
    Gardner, P
    Moss, R
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2005, 133A (01) : 103 - 105
  • [37] Cystic fibrosis mutation testing in Italy
    Bombieri, C
    Pignatti, PF
    [J]. GENETIC TESTING, 2001, 5 (03): : 229 - 233
  • [38] MUTATION ANALYSIS IN CYSTIC-FIBROSIS
    BILLINGS, PR
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (01): : 62 - 62
  • [39] Genotype-Phenotype Correlation for Cystic Fibrosis According to Registry Center of Cystic Fibrosis
    Rafeey, Mandana
    Jabarpoor-Bonyadi, Morteza
    Vahedi, Leila
    [J]. CRESCENT JOURNAL OF MEDICAL AND BIOLOGICAL SCIENCES, 2020, 7 (01): : 124 - 129
  • [40] COMMON PULMONARY COMPLICATIONS OF CYSTIC FIBROSIS
    HOLSCLAW, DS
    [J]. CLINICAL PEDIATRICS, 1970, 9 (06) : 346 - &